GLRX Human Pre-designed siRNA Set A contains three designed siRNAs for GLRX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLRX2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLRX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLRX3 Human Pre-designed siRNA Set A contains three designed siRNAs for GLRX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLRX5 Human Pre-designed siRNA Set A contains three designed siRNAs for GLRX5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLS Human Pre-designed siRNA Set A contains three designed siRNAs for GLS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Gls Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gls gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Gls Rat Pre-designed siRNA Set A contains three designed siRNAs for Gls gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLS2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLT1D1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLT1D1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLT8D1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLT8D1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLTP Human Pre-designed siRNA Set A contains three designed siRNAs for GLTP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Glucosamine Cholesterol (N-Cholesteryl succinyl glucosamine) is a glucosamine-based lipid conjugate, and can be used in the formation of lipid nanoparticles (LNPs)[1].

Glucosaminyl (N-acetyl) transferase 4 (GCNT4) is an enzyme. Glucosaminyl (N-acetyl) transferase 4 is significantly downregulated in gastric cancer and is associated with poor prognosis. Overexpression of Glucosaminyl (N-acetyl) transferase 4 can inhibit cell proliferation and the cell cycle[1].

Glucosaminyl (N-acetyl) transferase 4 (GCNT4) is an enzyme. Glucosaminyl (N-acetyl) transferase 4 is significantly downregulated in gastric cancer and is associated with poor prognosis. Overexpression of Glucosaminyl (N-acetyl) transferase 4 can inhibit cell proliferation and the cell cycle[1].

Glucosaminyl (N-acetyl) transferase 4 (GCNT4) is an enzyme. Glucosaminyl (N-acetyl) transferase 4 is significantly downregulated in gastric cancer and is associated with poor prognosis. Overexpression of Glucosaminyl (N-acetyl) transferase 4 can inhibit cell proliferation and the cell cycle[1].

GLUD1 Human Pre-designed siRNA Set A contains three designed siRNAs for GLUD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLUD2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLUD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GLUL Human Pre-designed siRNA Set A contains three designed siRNAs for GLUL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GluN2B-NMDAR antagonist-2 (compound S-58) is a potent, selective and cross the blood-brain barrier NMDAR-GluN2B antagonist with an IC50 value of 74.01, nM. GluN2B-NMDAR antagonist-2 shows mild cytotoxicity. GluN2B-NMDAR antagonist-2 decreases the cerebral infarction rates and neurologic deficit scores. GluN2B-NMDAR antagonist-2 has the potential for the research of stroke[1].

Glutathione diethyl ester (TFA) is a delivery agent for glutathione monoester, and thus for glutathione, in human cells and therefore could serve to decrease oxidative stress and toxicity[1].

Glutathione diethyl ester (TFA) is a delivery agent for glutathione monoester, and thus for glutathione, in human cells and therefore could serve to decrease oxidative stress and toxicity[1].

Glutathione diethyl ester (TFA) is a delivery agent for glutathione monoester, and thus for glutathione, in human cells and therefore could serve to decrease oxidative stress and toxicity[1].

Gluten, Wheat is a cohesive, visco-elastic proteinaceous material that can be extrated from wheat. Gluten, Wheat can be used to induce celiac disease[1].

Glutor is a selective GLUT 1/2/3 inhibitor that can inhibit glucose uptake. Glutor can inhibit glycolysis and effectively induce the death of cancer cells cultured in monolayers and spheroids[1].

Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs. Exatecan is a DNA topoisomerase I inhibitor that can be used in cancer research[1][2].

Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs. Exatecan is a DNA topoisomerase I inhibitor that can be used in cancer research[1][2].

Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs. Exatecan is a DNA topoisomerase I inhibitor that can be used in cancer research[1][2].

Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs. Exatecan is a DNA topoisomerase I inhibitor that can be used in cancer research[1][2].

Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs. Exatecan is a DNA topoisomerase I inhibitor that can be used in cancer research[1][2].

Gly-Mal-GGFG-Deruxtecan 2-hydroxy propionamide is a camptothecin-deriver and can be used as a drug linker for ADC.

Gly-Mal-GGFG-Deruxtecan 2-hydroxy propionamide is a camptothecin-deriver and can be used as a drug linker for ADC.

Gly-Mal-GGFG-Deruxtecan 2-hydroxy propionamide is a camptothecin-deriver and can be used as a drug linker for ADC.

GLYAT Human Pre-designed siRNA Set A contains three designed siRNAs for GLYAT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Glycerophospho-N-oleoyl ethanolamine (GNOE) is a serum metabolite. Glycerophospho-N-oleoyl ethanolamine can be used to study Bicuspid aortic valve (BAV) disease[1].

Glycerophospho-N-palmitoyl ethanolamine (GP-NPEA) is a metabolic precursor of palmitoyl ethanolamide PEA (HY-157829). Glycerophospho-N-palmitoyl ethanolamine decreases in the cortex of CUMS rats, which may be related to a disorder in the endocannabinoid system arising after the onset of depression[1].

Glycochenodeoxycholic acid 3-glucuronide is a type of steroid glucuronide and a plasma metabolite that can be used for biomarker research in diabetes and hepatocellular carcinoma (HCC)[1].

Glycogen phosphorylase-IN-1 (Compound 42) is an inhibitor for human liver glycogen phosphorylase (hlGPa) and hepatocyte glycogen-derived glucose production with IC50s of 53 and 380 nM, respectively. Glycogen phosphorylase-IN-1 reveals efficacy towards type 2 diabetes[1].

Glycolic acid (Standard) is the analytical standard of Glycolic acid. This product is intended for research and analytical applications. Glycolic acid is an inhibitor of tyrosinase, suppressing melanin formation and lead to a lightening of skin colour.

Glycolic acid (Standard) is the analytical standard of Glycolic acid. This product is intended for research and analytical applications. Glycolic acid is an inhibitor of tyrosinase, suppressing melanin formation and lead to a lightening of skin colour.

Glycolic acid (Standard) is the analytical standard of Glycolic acid. This product is intended for research and analytical applications. Glycolic acid is an inhibitor of tyrosinase, suppressing melanin formation and lead to a lightening of skin colour.